Danushka K. Wijesundara
ORCID: 0009-0004-3670-1906Also affiliated with Vaxxas (Australia)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial”.
Francesca L. Mordant, Zheyi Li, Danushka K. Wijesundara, Paula Ellenberg, Julia Lackenby +30 more
C. M. Williams, Danushka K. Wijesundara, Yoichi Furuya, Sreeja Biswas Roy
Makutiro G. Masavuli, Zelalem A. Mekonnen, Yanrui Li, Danushka K. Wijesundara, Ashish C. Shrestha +4 more
C. M. Williams, Julián Pardo, Danushka K. Wijesundara, Yoichi Furuya, Sreeja Biswas Roy
Sreeja Biswas Roy, Wei Sun, Andrea M Furuya, Danushka K. Wijesundara, Yoichi Furuya +1 more